Yatırımcı.AI

ECILC vs CLEBI Comparison

Price, market cap, valuation, profitability and leverage metrics of ECILC and CLEBI side by side.

ECILCCLEBI
StockFund

If You Had Invested TRY 10,000

Metric Comparison

ECILC vs CLEBI Comparison
MetricECILCCLEBISector median
Last price (TL)63.601,362.0018.72
Daily change−7.15%−2.71%−5.57%
Market capTRY 43.6BTRY 33.1BTRY 4.3B
P/E—9.9117.35
P/B0.684.851.09
Dividend yield2.04%5.11%0.90%
Return on equity−3.08%46.07%1.78%
Free float22.02%10.05%37.21%
Ratios are calculated from the latest published financial statements.

Popular Comparisons

Related Pages

About the ECILC vs CLEBI Comparison

Price, market cap, valuation multiples, profitability and leverage of ECILC (Eczacıbaşı İlaç) and CLEBI (Celebi) side by side as of Sep 28, 2026, 13:42. Of the 16 metrics compared, ECILC leads in 6 and CLEBI leads in 10.

Highlights: Daily change: CLEBI leads (−2.71% vs −7.15%). Market cap: ECILC leads (TRY 43.6B vs TRY 33.1B). P/B: ECILC leads (0.68 vs 4.85). EV/EBITDA: CLEBI leads (6.93 vs 165.19). EV/Sales: CLEBI leads (3.88 vs 9.35). Dividend yield: CLEBI leads (5.11% vs 2.04%). Gross margin: ECILC leads (37.83% vs 29.16%). EBITDA margin (annual): CLEBI leads (27.86% vs 11.49%).

Frequently Asked Questions

By P/E, Tie is cheaper (— vs 9.91); by P/B, ECILC trades at the lower multiple (0.68 vs 4.85).

Annual net margin is −20.86% for ECILC and 16.41% for CLEBI; return on equity is −3.08% for ECILC and 46.07% for CLEBI.

The leverage ratio is 18.92 for ECILC and 65.70 for CLEBI; net debt/EBITDA is 1.37 for ECILC and 1.10 for CLEBI. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.